Skip to content
OpenCapital
Get started

Constellium CSTM Accounts payable and other current liabilities (Note 11)

Accounts payable and other current liabilities (Note 11) at other companies

Eastman Chemical logo
Eastman ChemicalEMN
——

Other financials

Income statement

See full
Revenue$2.5B+24.4%
Gross profit$420.0M+59.7%
Net income$199.0M+438%
EPS (diluted)$1.42+446%

Balance sheet

See full
Cash & equivalents$143.0M+21.2%
Total debt$2.0B-4.1%
Total equity$1.1B+50.2%
Total assets$5.8B+13.1%

Cash flow

See full
Operating cash flow$73.0M+25.9%
CapEx$72.0M+4.3%
Free cash flow$1.0M+109%

Valuation

See full
Market cap$4.63B+129%

Profitability

See full
Gross margin15%+2.2pp
Net margin4.9%—
FCF margin1.9%+1.4pp

Returns & leverage

See full
Return on equity46.7%—
Debt / equity1.8×-1.0×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by Constellium in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.

The official record: Constellium’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Constellium's accounts payable and other current liabilities (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Constellium's accounts payable and other current liabilities (note 11)?
Constellium (CSTM) reported accounts payable and other current liabilities (note 11) of $1.97B in Q1 2026.
How has Constellium's accounts payable and other current liabilities (note 11) changed year-over-year?
Constellium's accounts payable and other current liabilities (note 11) increased by 18.5% year-over-year, from $1.67B to $1.97B.
What is the long-term trend for Constellium's accounts payable and other current liabilities (note 11)?
Over 2 years (2023 to 2025), Constellium's accounts payable and other current liabilities (note 11) has grown at a 8.9% compound annual growth rate (CAGR), from $1.41B to $1.67B.